Retour
Également cotée sous
INRLF
OTC
Fourchette du Jour
6,37 €
6,87 €
Fourchette 52 Semaines
5,43 €
12,25 €
Volume
759 909
Moyenne 50J / 200J
10,28 €
/
9,00 €
Clôture Précédente
10,32 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -5,1 | 0,4 |
| P/B | 5,3 | 2,9 |
| ROE % | -77,0 | 3,8 |
| Net Margin % | -63,4 | 3,9 |
| Rev Growth 5Y % | -15,8 | 10,0 |
| D/E | 2,0 | 0,2 |
Points Clés
Revenue declined -15,84% annually over 5 years
Negative free cash flow of -57,38M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 18,84%
Capital efficient — spends only 2,57% of revenue on capex
Croissance
Revenue Growth (5Y)
-15,84%
Revenue (1Y)3,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-76,99%
ROIC-19,53%
Net Margin-63,35%
Op. Margin-46,74%
Sécurité
Debt / Equity
1,95
Current Ratio2,38
Interest Coverage-1,95
Valorisation
P/E Ratio
-5,05
P/B Ratio5,26
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3,00% | Revenue Growth (3Y) | 6,60% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -15,84% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 174,66M | Net Income (TTM) | -110,65M |
| ROE | -76,99% | ROA | -27,74% |
| Gross Margin | 38,66% | Operating Margin | -46,74% |
| Net Margin | -63,35% | Free Cash Flow (TTM) | -57,38M |
| ROIC | -19,53% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,95 | Current Ratio | 2,38 |
| Interest Coverage | -1,95 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -5,05 | P/B Ratio | 5,26 |
| P/S Ratio | 3,20 | PEG Ratio | -0,01 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 558,43M | Enterprise Value | 656,03M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 174,66M | 169,58M | 153,71M | 361,30M | 348,09M |
| Net Income | -110,65M | -12,25M | -101,43M | -143,28M | -73,43M |
| EPS (Diluted) | -1,32 | -0,17 | -1,46 | -2,48 | -1,50 |
| Gross Profit | 67,52M | 71,04M | 52,84M | 36,86M | 160,17M |
| Operating Income | -81,63M | 13,33M | -82,09M | -113,44M | -61,39M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 398,84M | 500,03M | 460,06M | 621,34M | 817,35M |
| Total Liabilities | 292,67M | 318,78M | 331,82M | 401,55M | 646,77M |
| Shareholders' Equity | 106,17M | 181,25M | 128,25M | 219,80M | 170,58M |
| Total Debt | 207,25M | 216,31M | 208,82M | 152,38M | 114,66M |
| Cash & Equivalents | 109,65M | 168,27M | 126,08M | 289,43M | 346,64M |
| Current Assets | 222,54M | 299,01M | 262,82M | 424,66M | 585,83M |
| Current Liabilities | 93,33M | 114,58M | 158,86M | 277,39M | 368,98M |